On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…
On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterﾙ (DBC) platform….
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
On Aug. 18, 2020, scientists from the Max Planck Institute for Biophysics, the Paul Ehrlich Institute, the European…
On Aug. 17, 2020, Novavax announced the beginning of a Phase 2b clinical trial in South Africa to…
On Aug. 14, 2020, AstraZeneca concluded an agreement with the European Commission (EC) to supply up to 400…
On Aug. 14, 2020, Medigen Vaccine Biologics (MBV) published preclinical results of their COVID-19 vaccine candidate in BioRxiv,…
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as…
On Aug. 11, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
On Aug. 7, 2020, Altimmune announced that it has completed enrollment in its Phase 1b clinical trial of…
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…